Arnst, C. (1998). Is good marketing bad medicine. Business Week, 4(13), 62–63.
Barer, M.L., McGrail, K.M., Cardiff, K, Wood, L., & Green, C.J. (2000). Tales from the other drug wars. Vancouver: Centre for Health Services and Policy Research.
Barer, ML., Evans, R.G., Hertzman, C., & Lomas, J. (1987). Aging and health care utilization: new evidence on old fallacies. Social Science & Medicine, 24(10), 851–862.
Barer, M.L., Evans, R.G., & Hertzman, C. (1995). Avalanche or glacier?: Health care and the demographic rhetoric. Canadian Journal on Aging, 14(2), 193–224.
Barer, M.L., Evans, R.G., Hertzman, C., & Johri, M. (1998). Lies, damned lies, and health care zombies: Discredited ideas that will not die. HPI Discussion Paper 10, Health Policy Institute, The University of Texas-Houston, Health Science Center, 03.
Baumol, W., & Bowen, W.G. (1966). Performing arts - the economic dilemma. New York: Twentieth Century Fund.
Boulet, J.A., & Grenier, G. (1978). Health expenditures in Canada and the impact of demographic changes on future government health insurance program expenditures. Discussion Paper #123, Ottawa, Economic Council of Canada.
Canadian Institute for Health Information (CIHI). (2000). National health expenditure trends: 1976-2000. Ottawa: Canadian Institute for Health Information.
Chen, J., & Millar, W.J. (2000). Are recent cohorts healthier than their predecessors? Health Reports, 11(4), 9–24.
Clark, D.O., Von Korff, M., Saunders, K., Baluch, W.M., & Simon, G.E. (1995). A chronic disease score with empirically derived weights. Medical Care, 33(8), 783–795.
Denton, F.T., & Spencer, B.G. (1975). Health-care costs when the population changes. Canadian Journal of Economics, 7(1), 34–48.
Evans, R.G. (2001). Financing health care: Taxation and the alternatives. In Mossialos, E., Dixon, A., & Figueras, J. (Eds.), Funding health care: Options for Europe. Buckingham: Open University Press, forthcoming.
Evans, R.G., Barer, M.L., Stoddart, G.L., & Bhatia, V. (1994). Who are the zombie masters, and what do they want? Toronto: The Premier's Council on Health, Well-being and Social Justice.
Foot, D.K. (2000). [untitled review of Peterson, 1999] Canadian Public Policy-Analyse de Politiques, 42(4), 498–500.
Fries, J.F. (1980). Aging, natural death, and the compression of morbidity. New England Journal of Medicine, 303(3), 130–135.
Gee, E.M., & Gutman, G.M. (2000). The overselling of population aging: Apocalyptic demography, intergenerational challenges and social policy. Don Mills, ON: Oxford.
Health Services Utilisation and Research Commission (HSURC). (1998). Hospital and home care study. Saskatoon: Health Services Utilisation and Research Commission.
Henripin, J. (1994). The financial consequences of population aging. Canadian Public Policy-Analyse de Politiques, 20(1), 78–84.
Hill, M.N., Levine, D.M., & Whelton, P.K. (1988). Awareness, use, and impact of the 1984 Joint National Committee Consensus Report on High Blood Pressure. American Journal of Public Health, 78(9), 1190–1193.
Maclure, M., Dormuth, C., Naumann, T., McCormack, J., Rangno, R., Whiteside, C., & Wright, J.M. (1998). Influences of educational interventions and ad-verse news about calcium-channel blockers on first-line prescribing of antihypertensive drugs to elderly people in British Columbia, The Lancet, 352, 943–978.
Martel, L., & Bélanger, A. (1999). An analysis of the change in dependence-free life expectancy in Canada between 1986 and 1996. In Report on the demographic situation in Canada. Current demographic analysis (pp. 164–183). Ottawa: Statistics Canada.
McAlister, F.A., Teo, K.K., Lewanczuk, R.Z., Wells, G., & Montague, T.G. (1997), Contemporary practice patterns in the management of newly diagnosed hypertension. Canadian Medical Association Journal, 157(1), 23–30.
McGrail, KM., Evans, R.G., Barer, M.L., Sheps, S.B., Hertzman, C., & Kazanjian, A. (2001). The quick and the dead: Managing’ inpatient care in British Columbia hospitals, 1969-1995/96. Health Services Research, forthcoming.
Michael, P., Phillips, C., & Mulrow, C. (2000). Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials. British Medical Journal, 321, 983–986.
Mintzes, B. (2000). The truth, the half-truth and nothing like the truth. In Barer, M.L., McGrail, KM., Cardiff, K., Wood, L., & Green, C. J. (Eds), Tales from the other drug wars. Vancouver: Centre for Health Services and Policy Research.
Morgan, S.G. (2001). An index approach to drug expenditure decompositions, Discussion Paper, Health Policy Research Unit, Centre for Health Services and Policy Research, Vancouver, BC.
Newhouse, J.P. (1977). Medical-care expenditure: A cross-national survey. Journal of Human Resources, 12(1), 115–125.
Northcott, H.C. (1994). Public perceptions of the population aging “crisis”. Canadian Public Policy-Analyse de Politiques, 20(1), 66–77.
Pascali, M.V. (1995). Controlling expenditures for physicians’ services: An evaluation of British Columbia's cost containment policies, 1979-1991. Doctoral dissertation (Health Services and Policy Analysis), University of California at Berkeley.
Peterson, P.G. (1999). Grey dawn: How the comingage wave will transform America and the world. New York: Times Books.
Robson, W.P.B. (2001). Will the baby boomers bust the health budget? CD. Howe Institute Commentary 148. Toronto: Renouf Publishing.
Roos, N.P. (2000). The disconnect between the data and the headlines. Canadian Medical Association Journal, 163(4), 411–412.
Savoie, I. (2000). lipid lowering drugs. In Barer, M.L., McGrail, KM.Cardiff, K., Wood, L., Green, C.J. (Eds), Tales from the other drug wars. Vancouver: Centre for Health Services and Policy Research.
Savoie, I., Wright, J.M., & Maclure, M. (1998). Lipid lowering therapy. Joint Health Technology Assessment Series. BCOHTA, Vancouver, 1998, 4J.
Statistics Canada. (1999). How healthy are Canadians? Health Reports, special issue, 11(3).
Steinberg, E.P., Gutierrez, B., Momoni, A., Boscarino, J.A., Neuman, P., & Deverka, P. (2000). Beyond survey data: A claims-based analysis of drug use and spending by the elderly. Health Affairs, 19(2), £198-211.
Thomas, L. (1971). The technology of medicine. New England Journal of Medicine, 284, 1366–1368.
Van Tielen, R., Payes, F., & Genart, J. (1998). The demographic impact on ambulatory pharmaceutical expenditure in Belgium. Health Policy, 45, 1–14.
Woods Gordon Management Consultants. (1984). Investigation of the impact of demographic change on the health care system in Canada - Final Report. (Prepared for the Task Force on the Allocation of Health Care Resources (Joan Watson, chairman). Toronto: Woods Gordon.
Wright, C.J., Cardiff, K., & Kilshaw, M. (1997). Acute medical beds: How are they used in British Columbia? Vancouver: Health Policy Research Unit 07:D, Centre for Health Services and Policy Research.
Wright, J.M., Lee, C.H., & Chambers, G.K. (1999). Systematic review of antihypertensive therapies: Does the evidence assist in choosing a first-line drug? Canadian Medical Association Journal, 161(1), 25–32.